London [UK]/ Bengaluru (Karnataka) [India], May 22 (ANI/PRNewswire): SKAN Research Trust, promoted by Indian entrepreneur Ashok Soota and UK-based Quadram Institute Bioscience have entered into a Comprehensive Partnership Agreement to collaborate on research programmes focused on gut health
Individual healthcare professionals may benefit from interventions targeted at lowering work-related stress for up to a year after they are implemented. The findings of a Cochrane review of the most recent available data built on the findings of a previous analysis in 2015, which revealed lo
Cancer is still one of the major causes of mortality in the globe. Researchers are continually exploring for novel medicines that have better anticancer efficacy, less side effects, and are less expensive. The capacity of certain bacteria to selectively grow inside hypoxic tumours, i.e., cel
bout 1 in 26 people have epilepsy, and the most common type, temporal lobe epilepsy (TLE), is frequently ineffectively treated with anti-seizure drugs. Neurosurgery may be necessary for patients with this type of epilepsy in order to stop their seizures. Uncertainty surrounds the causes and
A novel cell signalling route was discovered by researchers at the Johns Hopkins Kimmel Cancer Centre that may one day be used as a therapeutic target for people with aggressive pancreatic cancer.
According to a new health data analysis led by UCL researchers, talking therapies can be used effectively to treat depression in adults over 45. This treatment may be associated with lower rates of future cardiovascular disease.
According to a new health data analysis led by UCL researchers, using talking therapies to effectively treat depression in adults over 45 may be associated with lower rates of future cardiovascular disease.
Researchers are increasingly using the blood-brain barrier, which allows only certain molecules to pass from the blood into the brain, to get therapies into the brain after a stroke.
A startling 89 per cent of desmoplastic melanoma patients in a nationwide clinical study responded to immunotherapy (pembrolizumab) alone, indicating that many patients could avoid the potential side effects of combination therapies and achieve disease control with this course of treatment.
Using technology created by a researcher at UTHealth Houston, a new study shows that the presence of a misfolded alpha-synuclein protein can be used to identify persons with Parkinson's disease. The discovery of this biomarker may lead to the creation of more accurate diagnostic equipment an
Gurgaon (Haryana) [India], April 14 (ANI/BusinessWire India): Art of Healing Cancer, a globally renowned Precision and integrative oncology institution located in Gurgaon, underscores the possible benefits of incorporating the anti-malarial drug, Artesunate, into cancer treatments. This insi